GlassScriptPhysician profile
Patrick Edward Sizemore
NPI 1679575013
$9,838.83
in general payments reported to CMS, 2019-2025
17 companies · $1,443 in 2025
The $1,443 reported for 2025 was more than what 77% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,011 · 2020: $14.10 · 2021: $114 · 2022: $20.20 · 2023: $220 · 2024: $7,017 · 2025: $1,443.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $7,250 · Travel and Lodging: $725 · Food and Beverage: $704.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $7,250.00 |
| Travel and Lodging | $725.26 |
| Food and Beverage | $704.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,297.41 | 2019-2025 | Da Vinci Surgical System |
| Globus Medical, INC. | $815.84 | 2019 | |
| Smith+Nephew, INC. | $231.73 | 2024-2025 | Grafix Pl, Collagenase Santyl |
| Conmed Corporation | $103.55 | 2024 | Airseal, Conmed Trocars |
| Peerless Surgical INC. | $67.06 | 2024-2025 | |
| Innocoll Pharmaceuticals Limited | $52.39 | 2021 | |
| Davol INC. | $51.30 | 2019-2022 | |
| Organogenesis INC. | $48.01 | 2021 | |
| Boston Scientific Corporation | $27.02 | 2019-2021 | |
| Innovation Technologies INC | $24.10 | 2023 | Irrisept |
| Convatec INC. | $21.77 | 2025 | |
| Polynovo North America LLC | $20.60 | 2023 | |
| Otsuka America Pharmaceutical, INC. | $19.43 | 2019 | |
| Ethicon US, LLC | $16.11 | 2025 | Surgicel Nu-Knit, Ethicon |
| Paratek Pharmaceuticals, INC. | $15.85 | 2024 | Nuzyra |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanara Medtech INC. | $14.10 | 2020 | |
| Endogastric Solutions, INC | $12.56 | 2024 | Esophyx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Sizemore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.